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Post-transcriptional regulationRNA-binding proteins (RBPs) are key players in the post-transcriptional regulation of gene expression.
Precise knowledge about their binding sites is therefore critical to unravel their molecular function
and to understand their role in development and disease. Individual-nucleotide resolution UV crosslink-
ing and immunoprecipitation (iCLIP) identiﬁes protein–RNA crosslink sites on a genome-wide scale. The
high resolution and speciﬁcity of this method are achieved by an intramolecular cDNA circularization
step that enables analysis of cDNAs that truncated at the protein–RNA crosslink sites. Here, we describe
the improved iCLIP protocol and discuss critical optimization and control experiments that are required
when applying the method to new RBPs.
 2013 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-ND license. 1. Introduction
Post-transcriptional regulation critically contributes to the abil-
ity of cells to adjust gene expression in the face of a changing exter-
nal or internal environment [1]. RNA-binding proteins (RBPs) are
the primary regulatory factors of the various post-translational
stages, including alternative splicing, polyadenylation, mRNA
localization, translation and degradation [2]. Their RNA binding is
mediated by modular RNA-binding domains (RBDs), such as the
RNA recognition motif (RRM), hnRNP K-homology domain or zinc
ﬁngers (Znf) [3]. Although many RBDs recognize RNA in a se-
quence-speciﬁc manner, sequence information is not sufﬁcient to
reliably predict RBP binding sites throughout the transcriptome.
In particular, RBPs cooperate and compete when binding to RNA;
therefore it is crucial to study protein–RNA interactions in the cel-
lular environment.
The ﬁrst approaches to investigate protein–RNA complexes
in vivo employed afﬁnity puriﬁcation or immunoprecipitation
combined with microarray analysis (RIP-CHIP). However, these ap-proaches were prone to identifying non-physiologic or indirect
interactions and their low resolution made it difﬁcult to narrow
down actual binding sites [4,5]. Development of in vivo UV-cross-
linking and immunoprecipitation (CLIP) enabled the study of pro-
tein–RNA interactions with high positional resolution and
speciﬁcity. Combined with high-throughput sequencing, CLIP be-
came the standard tool for the genome-wide analysis of protein–
RNA interactions [6].
In the original CLIP approach, reverse transcription needs to
proceed from a universal 30 ligated adapter to a universal 50 ligated
adapter, since both adapters are required for PCR ampliﬁcation.
However, in over 80% of cases, the reverse transcriptase stalls at
the short polypeptide left at the UV-induced crosslink site, result-
ing in truncated cDNAs that lack the 50 adapter, and are therefore
not ampliﬁed in CLIP [7]. We previously developed individual-
nucleotide resolution CLIP (iCLIP), which enables PCR ampliﬁcation
of truncated cDNAs, and thereby identiﬁes protein–RNA crosslink
sites with nucleotide resolution (Fig. 1) [8]. iCLIP has been
successfully used to study the function of RBPs in alternative splic-
ing [8–13], alternative polyadenylation [14], RNA methylation [15]
and mRNA stability [16]. It determined high-resolution RNA
splicing maps of different RBPs, which enabled to assess how the
position of RBP binding around alternative exons determines
their splicing function [8–13,17]. Importantly, in addition to iden-
tifying the RBP binding sites of an RBP, iCLIP can also quantitate
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Fig. 1. Schematic representation of the iCLIP procedure identifying RNA–protein interactions in intact cells. Cells are irradiated with UV-C light on ice, leading to formation of
a covalent bond between protein and RNA. This is followed by partial RNase digestion and an immunoprecipitation with protein-speciﬁc antibodies. For the library
preparation and visualization, the RNA is dephosphorylated, a 30 end adapter is ligated and the 50 end is radioactively labeled. The complexes are separated by SDS–PAGE and
isolated from a nitrocellulose membrane according to the expected size. The protein is then digested by proteinase K, and reverse transcription (RT) is performed truncating at
the remaining polypeptide. The RT primer introduces two cleavable adapter regions and barcode sequences. The free RT primers are removed by size selection and
circularization of the cDNA is carried out. Linearization generates suitable templates for PCR ampliﬁcation. In the last step, high-throughput sequencing generates reads in
which the barcode sequences are immediately followed by the last nucleotide of the cDNA.
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it was demonstrated that the splicing factor U2AF65 gains access
to hundreds of Alu elements after knockdown of hnRNP C, which
prevents their erroneous recognition under normal conditions
[18].
The iCLIP protocol starts with UV irradiation, which forms
covalent bonds at sites of protein–RNA interactions and thereby
preserves the in vivo binding pattern (Fig. 1, step 1). Next, the
cells are lysed and the RNAs are partially digested to obtain
RNA fragments in an optimal size range (Fig. 1, steps 2 and 3).
After immunoprecipitation of the protein–RNA complexes, the
RNA is dephosphorylated, an adapter is ligated to the 30 end of
the RNA and the 50 end is radioactively labeled (Fig. 1, steps 4–
7). SDS–PAGE and transfer to nitrocellulose membrane enable to
remove free RNA and to stringently purify the crosslinked pro-
tein–RNA complexes (Fig. 1, step 8). The RNA is recovered from
the nitrocellulose membrane by digesting the protein with pro-
teinase K, which leaves a polypeptide at the crosslink site
(Fig. 1, step 9). The RNA is then reverse transcribed into cDNA,
which most often truncates at the polypeptide remaining at thecrosslink site (Fig. 1, step 10). Size selection of the cDNA removes
free reverse transcription (RT) primers, and is followed by cDNA
circularization, which attaches the second adapter to the 30 end
of cDNA (Fig. 1, steps 11–13). Restriction enzyme digestion linea-
rizes the cDNA before PCR ampliﬁcation (Fig. 1, steps 14 and 15).
To increase the quantitative power of the method, the reverse
transcription primers contain a randomized sequence (random
barcode), which enables computational ﬁltering of artifacts
caused by variable PCR ampliﬁcation of the cDNAs [19]. After
high-throughput sequencing, the barcode sequence precedes the
cDNA sequence. Truncated cDNAs represent over 80% of the cDNA
library, and after mapping their sequence to the genome, the po-
sition of the preceding nucleotide corresponds to the crosslinking
site [7].
In the following section, we provide a detailed description of re-
quired materials and experimental procedures of the iCLIP proto-
col. In particular, we introduce important controls and
optimization steps including some example experiments. Through-
out the protocol, we point out critical steps and give advice on how
to optimize them.
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2.1. Buffers for standard iCLIP protocolBuffer IngredientsLysis buffer 50 mM Tris–HCl, pH 7.4
100 mM NaCl
1% Igepal CA-630
0.1% SDS
0.5% sodium deoxycholate
On the day: 1/100 volume of
Protease Inhibitor Cocktail
Set III, for tissues: 1/1000
volume of ANTI-RNaseHigh-salt Wash 50 mM Tris–HCl, pH 7.4
1 M NaCl
1 mM EDTA
1% Igepal CA-630
0.1% SDS
0.5% sodium deoxycholatePNK buffer
Man20 mM Tris–HCl, pH 7.4
10 mM MgCl2
0.2% Tween-20Fishe5x PNK pH 6.5 buffer
BD M
Sigm350 mM Tris–HCl, pH 6.5
50 mM MgCl2
5 mM dithiothreitol
Freeze aliquots of the buffer,
do not thaw and freeze again4x Ligation buffer 200 mM Tris–HCl, pH 7.8
40 mM MgCl2
4 mM dithiothreitol
Freeze aliquots of the buffer,
do not thaw and freeze againPK buffer 100 mM Tris–HCl, pH 7.4
50 mM NaCl
10 mM EDTAPK buffer + 7 M urea 100 mM Tris–HCl, pH 7.4
50 mM NaCl
10 mM EDTA
7 M urea2.2. Materials for UV crosslinking and immunoprecipitationMaterial ManufacturerStratalinker UV crosslinker
2400Stratagene4-Thiouridine Sigma (T4509)
Protein G Dynabeads Life Technologies (10004D)
Protein A Dynabeads Life Technologies (10002D)
Protease Inhibitor Cocktail
Set IIICalbiochem/Merck (539134-
1SET)ANTI-RNase Life Technologies (AM2692)
RNase I Life Technologies (AM2295)
Turbo DNase Life Technologies (AM2238)
T4 PNK plus 10x PNK buffer NEB (M0201L)
RNasin Promega (N2515)
Proteus Clariﬁcation Mini
Spin ColumnsGeneron (GEN-MSF500)T4 RNA Ligase I NEB (M0204L)
Pre-adenylated adapter L3-App IDT (rAppAGATCGGAAGAGCG
GTTCAG/ddC/)
ATP [c-32P] Perkin Elmer (NEG502A250UC)(Continued on next page)2.3. SDS PAGE and nitrocellulose transferMaterial Manufacturer4–12% NuPAGE gels Life Technologies (NP0322BOX)
Electrophoresis chamber Life Technologies (EI0002)
Transfer apparatus Life Technologies (EI0002)
LDS-4x sample buffer Life Technologies (NP0007)
Pre-stained protein marker Fermentas (SM1811)
Nitrocellulose membrane
protran BA85VWR (732-4174)Sponge pads for XCell II
blottingLife Technologies (EI9052)20  transfer buffer Life Technologies (NP0006-1)
20MOPS-SDS running buffer Life Technologies (NP0001)
Whatman ﬁlter paper GE Healthcare (3030917)
Film Fuji (4741019236)2.4. RNA isolationMaterial ufacturerProteinase K r Scientiﬁc (YSJ-762-Q)
19G syringe needles icrolance (304000)
Phenol/chloroform a (P3803)
Phase lock gel heavy tube (713-2536)
Glycoblue ion (9510)
3 M sodium acetate pH 5.5 echnologies (AM9740)VWR
Amb
Life T
2.5. Reverse transcriptionMaterial ManufacturerPCR tubes VWR (732-0545)
dNTPs Promega (1009310)
Superscript III Life Technologies (18080085)
5X First-strand buffer Life Technologies (18080085)
DTT Life Technologies (18080085)
1 M HEPES pH 7.3 Thermo Scientiﬁc (BP299-500)
TE buffer VWR (A2575)Name Sequence (IDT)Rt1clip /5Phos/NNAACCNNNAGATCGGA
AGAGCGTCGTGgatcCTGAACCGCRt2clip /5Phos/NNACAANNNA
GATCGGAAGAGCGTCGTGgatcCT
GAACCGCRt3clip /5Phos/NNATTGNNNAGATCGGA
AGAGCGTCGTGgatcCTGAACCGCRt4clip /5Phos/NNAGGTNNNAGATCG
GAAGAGCGTCGTGgatcCTGAA
CCGCRt6clip /5Phos/NNCCGGNNNAGATC
GGAAGAGCGTCGTGgatcCTGAA
CCGCRt7clip /5Phos/NNCTAANNNAGATCGGA
AGAGCGTCGTGgatcCTGAACCGCRt8clip /5Phos/NNCATTNNNAGATCGGA
AGAGCGTCGTGgatcCTGAACCGC
thods 65 (2014) 274–287 277Name Sequence (IDT)I. Huppertz et al. /MeRt9clip /5Phos/NNGCCANNNAGATCGG
AAGAGCGTCGTGgatcCTGAAC
CGCRt11clip /5Phos/NNGGTTNNNAGATCGGA
AGAGCGTCGTGgatcCTGAACCGCRt12clip /5Phos/NNGTGGNNNAGA
TCGGAAGAGCGTCGTGgatcCT
GAACCGCRt13clip /5Phos/
NNTCCGNNNAGATCGGAA
GAGCGTCGTGgatcCTGAACCGCRt14clip /5Phos/NNTGCCNNNAG
ATCGGAAGAGCGTCGTGgatc
CTGAACCGCRt15clip /5Phos/
NNTATTNNNAGATCGGAA
GAGCGTCGTGgatcCTGAACCGCRt16clip /5Phos/
NNTTAANNNAGATCGGAAG
AGCGTCGTGgatc CTGAACCGC2.6. cDNA isolationMaterial Manufacturer2x TBE – urea loading buffer Life Technologies (LC6876)
6% TBE – urea pre-cast gels Life Technologies (EC68652B)
Low molecular weight
markerNEB (N3233L)TBE running buffer Life Technologies (LC6675)
SYBR green II Life Technologies (S-7564)
19G syringe needle BD Microlance (300637)
Glass pre-ﬁlters Whatman (1823010)
Phase lock gel heavy VWR (713-2536)
Costar SpinX column Corning Incorporated (8161)2.7. Ligation of the primer to the 50 end of the cDNAMaterial Manufacturer10x CircLigase buffer Cambio (CL9025K)
CircLigase II Cambio (CL9025K)
MnCl2 Cambio (CL9025K)
Cut_oligo GTTCAGGATCCACGACGCTCT
TCaaaa
BamHI Fermentas, FD0055
Fast digest buffer Fermentas, FD00552.8. PCR amplifcationMaterial ManufacturerAccuprime Supermix I Life Technologies (12342028)
SYBR green I Life Technologies (S-7563)
P5 AATGATACGGCGACCACCGAGA
TCTAC ACTCTTTCCCTACACGA
CGCTCTTCCGATCTP3 CAAGCAGAAGACGGCATACGA
GATCGGTCTCGGCATTCCTG
CTGAACCGCTCTTCCGATCT2.9. qPCR quantitationMaterial ManufacturerAccuprime Supermix I Life Technologies (12342028)
PhiX control library
(RNAseq/ChIPseq)Illumina (PC-110-3001)Platinium Taq mastermix Life Technologies (11743100)
DLP [6FAM]
CCCTACACGACGCTCTTCCGATCT
[TAMRA]Primer 1 AATGATACGGCGACCACCGAGATC
Primer 2 CAAGCAGAAGACGGCATACGAGATC2.10. Buffers for stringent urea iCLIP protocolBuffer IngredientsUrea cracking buffer 50 mM Tris–HCl, pH 7.4
6 M urea
1% SDS
25% PBST-20 IP buffer 50 mM Tris–HCl, pH 7.4
150 mM NaCl
0.5% Tween 20
0.1 mM EDTA2.11. Stringent urea iCLIPMaterial ManufacturerDynabeads Antibody
Coupling KitLife Technologies (14311D)SUPERase in™ RNase
inhibitorLife Technologies (AM2694)NuPAGE sample
reducing agentLife Technologies (NP0004)NuPAGE antioxidant Life Technologies (NP0005)
Linear acrylamide Life Technologies (AM9520)3. iCLIP protocol
In this manuscript, we provide a detailed iCLIP protocol with
comments, tips and explanations provided in the footnotes. For
the most critical steps, we describe the results of example experi-
ments at the end of the subchapters. We also provide a table sum-
marizing the recent improvements and quality assessments, which
facilitate an optimal library preparation for your protein of interest
(Table 1). We present tests for various critical steps including
dephosphorylation, sonication and alkaline hydrolysis. We also de-
scribe how to optimize the concentration of RNase I, and test the
efﬁciency of reverse transcription primers. This optimized protocol
enables the user to overcome the technical challenges of iCLIP, and
ensures the comprehensive identiﬁcation of protein–RNA
interactions.
Moreover, we provide protocols for two alternative procedures.
In Section 3.1.2, we describe pre-incubation of cells with photo-
reactive ribonucleosides, such as 4-thiouridine, which enables
crosslinking with UV-A rather than UV-C light [20]. Since pre-incu-
bation of cells with 4-thiouridine enhances crosslinking of some
proteins [21], we tested and integrated it as an alternative entry
point into the iCLIP protocol (PAR-iCLIP). In Section 3.10, we
Table 1
Improvements compared to the previous protocol, which was published in the Journal of Visualized Experiments [19].
Original protocol Improved protocol Reason for the change Beneﬁt of the change
25 and 40 mM dithiothreitol in the 5x
PNK pH 6.5 and the 4x ligation
buffer, respectively
5 and 4 mM dithiothreitol in the 5x
PNK pH 6.5 and the 4x ligation
buffer, respectively
High concentration of DTT can decrease the
immunoprecipitation efﬁciency
Increased recovery of protein–RNA
complexes, as visualized on the
radiograph
No 4-thiouridine pre-incubation Optional 4-thiouridine pre-
incubation and UV-A crosslinking
Special modiﬁcations are required for
certain proteins
4-thiouridine enhances crosslinking of
certain proteins
Optional sonication Use of bioruptor enables uniform
sonication of multiple samples
Sonication shears the DNA, which releases
proteins from the chromatin
Increased recovery of protein–RNA
complexes, as visualized on the
radiograph (Fig. 2D)
Use phenol/chloroform pH 4.5 Use phenol/chloroform pH 6.7 L3 is a DNA adapter ligated to the RNA
creating an DNA–RNA hybrid
Reduction of DNA-RNA hybrids in
phenol phase
Radioactive RNA carried over into PCR Alkaline hydrolysis degrades RNA
after reverse transcription
The carryover RNA is radioactive and might
inhibit cDNA circularization
Reduction of radioactive signal after
reverse transcription (Fig. 4B)
No phenol/chloroform extraction after
cDNA recovery
Additional phenol/ chloroform
extraction after cDNA recovery from
TBE-urea gel
Carryover of urea and polyacrylamide after
gel extraction can decrease CircLigase II
efﬁciency
Increased efﬁciency of cDNA
circularization due to removal of
potential contaminants
Preparative PCR in the same volume
as the PCR optimization
Increased the volume of the
preparative PCR
High cDNA concentration in the preparative
PCR can introduce salts that may inhibit
PCR ampliﬁcation
Consistent efﬁciency of PCR
ampliﬁcation
No stringent urea treatment Optional stringent puriﬁcation
strategy with urea
Special modiﬁcations are required for
certain proteins
Removal of co-puriﬁcation of RBPs that
strongly interact with the protein of
interest (Fig. 5)
278 I. Huppertz et al. /Methods 65 (2014) 274–287describe a stringent puriﬁcation strategy that employs denatur-
ation with urea, which can be used to avoid co-puriﬁcation of RBPs
that strongly interact with the protein of interest.
3.1. Protein–RNA crosslinking
This chapter describes the experimental steps for UV-C or UV-A
crosslinking. All further steps of the iCLIP protocol (3.2–3.10) are
the same, regardless of the crosslinking procedure. We estimate
that for a standard experiment (one 10 cm diameter dish), we
use 8–10 million HeLa cells or 10–12 million HEK293 cells.
The input for other cell lines needs to be optimized.
3.1.1. UV-C crosslinking
 After culturing adherent cells in a 10 cm diameter plate, remove
the medium, add 6 ml of ice-cold PBS and place on ice.
 Irradiate cells with 150 mJ/cm2 at 254 nm in a Stratalinker 2400
or an equivalent instrument.1
 Scrape off the cells with cell lifters.
 Transfer the cell suspension into three 2 ml microtubes. Centri-
fuge at 514  g at 4 C for 1 min to pellet cells, and then remove
supernatant.
 Snap-freeze the cell pellets on dry ice and store at 80 C until
further use. Continue with step 3.2 or 3.10.
3.1.2. 4-Thiouridine labeling and UV-A crosslinking (alternative to step
3.1.1)
 Add 50 ll of 4SU (stock concentration: 100 mM 4SU) to a 10 cm
plate of cells cultured in 10 ml DMEM supplemented with FBS
and Pen/Strep to get a ﬁnal concentration of 500 lM 4SU
[22].2 Alternatively, add 10 ll of 4-thiouridine (stock concentra-
tion: 100 mM) to get a ﬁnal concentration of 100 lM 4SU [23].1 Crosslinking conditions can be optimized when working with a new protein,
however we do not see large increases in the efﬁciency of UV-C crosslinking with
energies higher than recommended in the protocol. Special care should be taken
when further increasing the dose, since this could distort library preparation due to
damaged RNA and could trigger DNA-damage response pathways in the cells.
2 4-Thiouridine is light-sensitive, therefore return the cells to the incubator quickly
after its addition. Incubate the cells with 4-thiouridine for 60 min at 500 lM or
for 8 h at 100 lM; afterward check the viability of your cells
under the microscope.
 Aspirate the medium and add 6 ml of ice-cold PBS to cells grow-
ing in a 10 cm plate (enough for three immunoprecipitations).
Remove the lid and place on ice.
 Irradiate once with 2  400 mJ/cm2 in a Stratalinker 2400 with
365 nm bulbs, or an equivalent instrument.
 Scrape off the cells with cell lifters.
 Transfer the cell suspension into three 2 ml microtubes. Centri-
fuge at 514  g at 4 C for 1 min to pellet cells, and then remove
supernatant.
 Snap-freeze the cell pellets on dry ice and store at 80 C until
further use. Continue with step 3.2.
Test: crosslinking technique. Pre-incubation of cells with photo-
reactive ribonucleosides, such as 4-thiouridine or 6-thioguanosine,
enables crosslinking with UV-A light as commonly used in pho-
toactivatable-ribonucleoside-enhanced CLIP (PAR-CLIP) [20],
which can enhance the crosslinking efﬁciency for certain RBPs
[21]. However, excess incorporation of these nucleotide analogs
can impair cellular function.
In order to test if photo-activatable nucleosides affect cell via-
bility, we measured the proliferation of HeLa and HEK293 cells
upon 6-thioguanosine or 4-thiouridine incubation (Fig. 2A and B).
We seeded the same number of cells for all conditions, let them
settle for a day and then added either 4-thiouridine or 6-thiogu-
anosine. The viable and dead cells were counted after a period of
0–96 h using trypan blue staining, and the number of viable cells
was normalized by the initial number of seeded cells.
These experiments indicated that the incubation with photo-
reactive nucleosides is toxic for the cells. Proliferation of HEK293
cells was stalled when incubated with 100 lM 4-thiouridine or
25 lM of 6-thioguanosine, and the number of HeLa cells decreased
at these concentrations, suggesting that photo-reactive nucleo-
sides lead to decreased proliferation in HEK293, and cell death in
HeLa cells (Fig. 2A and B). Only the lowest concentration (25 lM
of 4-thiouridine or 5 lM of 6-thioguanosine) allowed a limited
proliferation of HEK293 cells (Fig. 2A).
In order to minimize the toxic effects of photo-reactive nucleo-
sides, the optimal duration of incubation with the photo-activat-
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Fig. 2. Tests using photo-reactive nucleosides and sonication. (A) Increasing concentrations of 4-thiouridine (4SU) or 6-thioguanosine (6GU) lead to cell death in HeLa cells.
HeLa cells were treated with 4SU (4SU; 25 lM, 100 lM and 500 lM) or 6SG (6SG; 25 lM, 100 lM) over a time course of 96 h. Viable cells were counted using trypan blue
staining at different time points, and normalized to the initial cell numbers (depicted as log2). Dead cells were counted at each time point using trypan blue and displayed as
percentage of total cell numbers at this time point. (B) Increasing concentrations of 4SU or 6SG inhibit growth of HEK293 cells. HEK293 cells were treated with 4SU (25 lM,
100 lM and 500 lM) or 6SG (5 lM, 25 lM, 100 lM) over a time course of 96 or 48 h, respectively. Display as in (A). (C) hnRNP C can be crosslinked with either UV-C or UV-A
light in combination with 4SU. Autoradiograph showing radioactively labeled hnRNP C protein–RNA complexes. 4SU incubation for 30 and 60 min was followed by
crosslinking by UV-A light and compared to UV-C crosslinking. Samples without antibody serve as controls. The size of uncrosslinked hnRNP C protein is labeled on the right.
(D) Autoradiograph of radioactively labeled protein–RNA complexes immunoprecipitated with antibodies against endogenous TIA1 or hnRNP C. Since sonication can free
chromatin-associated proteins, samples were either sonicated or left untreated before immunoprecipitation, and RNA was digested with a 1/50 dilution of RNase I. Samples
without antibody serve as controls. Sizes of uncrosslinked proteins are labeled on the right. The asterisk indicates the hnRNP C dimer.
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Fig. 3. Tests for dephosphorylation and partial RNase digestion. (A) Optimization of
RNase I concentration is crucial to obtain optimal fragment sizes. Autoradiograph
showing hnRNP C protein–RNA complexes that were treated with decreasing concen-
trations ofRNase I before immunoprecipitation.Markings on the right (A–E) indicateﬁve
size ranges thatwere cut from the nitrocellulosemembrane. A samplewithout antibody
serves as control. Thesizes ofuncrosslinkedhnRNPCandhnRNPCdimers aremarkedby
an arrowhead and an asterisk, respectively. (B) Partial RNase digestion with a 1/250
dilutionyieldsanoptimaldistributionofrecoveredRNAfragmentsizes.Sizeseparationof
RNA fractions isolated from hnRNP C protein–RNA complexes through proteinase K
digestion. RNA was isolated from ﬁve regions of the nitrocellulose membrane (A–E, see
labeling in (A)) for three differently treated samples (1/50, 1/250 and 1/500 dilutions of
RNase I). (C) PNK treatment for20 min is themostefﬁcient for30 enddephosphorylation.
PTBprotein–RNAcomplexesweretreatedeitherwithShrimpAlkalinePhosphatase(SAP)
for20 minorwithPolynucleotideKinase (PNK) for20 minor2 h,and thecDNAyieldwas
compared after library preparation. A samplewithout antibody serves as control.
280 I. Huppertz et al. /Methods 65 (2014) 274–287able nucleoside should be determined. Combining 4-thiouridine-en-
hanced UV-A crosslinking with the iCLIP protocol (PAR-iCLIP), we
used immunoprecipitation of the RNA-binding protein hnRNP C as
a reference to estimate the optimal 4-thiouridine incubation period
(Fig. 2C). HEK293 cells were incubated for 30 or 60 min with 4-thio-
uridine, followed by UV-A crosslinking. For the labeling of nascent
RNA, short incubations were chosen with a higher concentration of
4-thiouridine [22]. For comparison, untreated cells were crosslinked
using standard UV-C irradiation. All experiments were performed
under low RNase conditions (see below). 30 and 60min of incubation
with 4-thiouridine recovered equal amounts of radioactive protein–
RNA complexes, which was similar to the amount recovered from
UV-C treated cells (Fig. 2C). Independent of the crosslinking tech-
nique, a radioactive smear was seen extending upwards from about
40 kDa (close to the molecular weight of hnRNP C), which represents
proteins crosslinked to RNA fragments of varying lengths. Control
experiments omitting the antibody conﬁrmed that non-speciﬁc
background signal is absent when using the iCLIP puriﬁcation condi-
tions with either crosslinking method. We conclude that the iCLIP
protocol is appropriate for studies of either UV-A or UV-C crosslinked
protein–RNA complexes. While UV-A does not increase the efﬁciency
of hnRNP C crosslinking, use of photo-activatable nucleoside and UV-
A crosslinking may increase crosslinking efﬁciency for other RBPs
[20]. It is important to keep in mind that hnRNP C is a predominantly
nuclear RBP, which mainly binds to pre-mRNA. When studying cyto-
plasmic RBPs, prolonged incubation with 4-thiouridine might be re-
quired in order to enable accumulation of labeled RNAs in the
cytoplasm. For the analysis of PAR-iCLIP data, it is important to keep
in mind that this protocol may require adjustment of the mapping
procedure, allowing an additional mismatch to accommodate the fre-
quent T-to-C transition in the reads (for UV-C crosslinking experi-
ments, we usually allow max. two mismatches within a read). A
thorough analysis of the relative occurrence of transitions versus
truncations in PAR-iCLIP remains to be done.
3.2. Immunoprecipitation
3.2.1. Bead preparation
 Add 100 ll of protein G Dynabeads per experiment to a fresh
microtube (use protein A Dynabeads for rabbit antibodies).
 Wash beads twice with lysis buffer (without protease inhibitor).
This and all following washing steps of the beads are performed
with 900 ll of the respective buffer.
 Resuspend the beads in 100 ll lysis buffer with 2–10 lg anti-
body per experiment.3
 Rotate tubes for 30–60 min at room temperature.
 Wash 3 times with 900 ll lysis buffer and leave in the last wash
until ready to proceed to step 3.2.3.
3.2.2. Cell lysis and partial RNA digestion
 Resuspend the cell pellet in 1 ml lysis buffer (with 1:100 Prote-
ase Inhibitor Cocktail Set III) and transfer to a 1.5 ml micro-
tube.4 Prepare enough lysate for two experimental samples
(low and high RNase) and appropriate controls.5
 Sonication of samples (Optional).3 The amount of required antibody depends on its quality and purity. This should
be optimized in preliminary experiments.
4 We suggest that the RNA or protein concentration is determined with Nanodrop or
Bradford assay, respectively, and normalized to the concentration of the sample with the
lowest amount. We recommend 2mg/ml as the optimal protein concentration.
5 Other recommended controls include a control where the RBP is absent from the
original material (such as knockout or knockdown cells), a control where no
crosslinking is done and a control where no antibody is used during IP.EITHER
 Sonicate the sample on ice using a probe sonicator. The probe
should be approximately 0.5 cm from the bottom of the tube
and not touching the tube sides in order to avoid foaming. Son-
icate twice with 10 s bursts at ﬁve decibels. Clean the probe by
sonicating H2O before and after sample treatment.OR
 Use Bioruptor plus for ﬁve cycles with alternating 30 s on/30 s
off at low intensity.
 Prepare two dilutions of RNase I in PBS6; we recommend to ini-
tially use a 1:50 dilution for high RNase and a 1:250 dilution for
low RNase, but this needs to be carefully optimized (see Fig. 3A
and comments at the end of this subchapter).
 Add10 ll of loworhighRNase Idilutionand2 ll TurboDNase to the
cell lysate and immediately place the samples at 37 C for 3min,
shaking at 1100 rpm. Immediately afterward transfer to ice for
>3min.
 Centrifuge for 10 min at 22,000  g and at 4 C to clear the
lysate. Carefully collect the supernatant (leave about 50 ll
lysate on the pellet to prevent carryover).
 Optional: load 500 ll of the lysate onto a Proteus Clariﬁcation
Mini Spin Column. Centrifuge for 1 min at 22,000  g at 4 C.
Transfer ﬂow-through to a new tube and place on ice. Repeat
for the rest of the lysate and combine the fractions.76 We ﬁnd that RNase I is deactivated after prolonged incubation with 0.1% SDS in
the lysis buffer.
7 To test a new antibody, collect 15 ll at this step for Western blot comparison of
lysate before and after IP and visualize depletion of protein.
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 Add the lysate to the beads and rotate for 1 h or overnight at
4 C.
 Place on magnet and discard the supernatant8, and wash twice
with high-salt wash (rotate the second wash for at least 1 min
at 4 C).
 Wash twice with PNK buffer and then leave in 1 ml PNK buffer
and proceed to step 3.3.Test: sonication. Genomic DNA can impair the purity and efﬁ-
ciency of immunoprecipitation, in particular if the protein of
interest directly interacts with chromatin. In addition to the
Turbo DNase treatment, an optional sonication step can be in-
cluded to shear the DNA. We tested the impact of this treat-
ment on two proteins commonly studied in our lab.
Sonication led to a minor improvement in the efﬁciency of
TIA1-RNA immunoprecipitation, but had no visible effect on
hnRNP C-RNA immunoprecipitation (Fig. 2D). However, it is
important to keep in mind that a speciﬁc subset of protein–
RNA complexes could be lost without sonication, even if no ef-
fect is visible on the gel. The sonication step is optional, how-
ever for nuclear RBPs either syringe treatment or sonication
are crucial for efﬁcient immunoprecipitation.9 If contaminating bands of other protein–RNA complexes are present above your
protein–RNA complex, only cut up to, but not including these bands. If the
contaminating bands run below your RNA–protein complex, cut an additional band
between the contaminating band and your protein–RNA complex. The RNA sequences
cloned from this band can later be used to compare with those puriﬁed with your
protein–RNA complexes to control for the speciﬁcity of your experiment.
10 Sections 3.3 and 3.4 do not need to be carried out on no-UV and high-RNase
controls. However, they should be performed on the no-antibody control to use it as a
background estimate for the complete library preparation.
11 Alternatively, truncated RNA ligase T4 R55K, K227Q can be used. Truncated T4Test: partial RNase digestion. The conditions of the partial RNase
digestion need to be optimized for successful library preparation.
The target size of puriﬁed RNAs is between 50 and 300 nucleo-
tides. Keep in mind that the crosslink site of the protein is at a
random position within these RNA molecules. Most often the re-
verse transcriptase stalls at the short polypeptide attached to the
RNAs. The percentage of truncated cDNAs can vary depending on
the protein, but we previously found that it is generally >80%
[7].
Therefore, on average, the resulting cDNA molecules will be
half the size of the RNA. To determine the optimal RNase I con-
centration, we tested dilutions ranging from 1:50 to 1:2000. In
our test experiment, the optimal digestion was observed with
the 1:250 dilution, which generated a diffuse signal of protein–
RNA complexes starting from 40 kDa, which is close to the molec-
ular weight of hnRNP C (Fig. 3A). In preliminary experiments, we
recommend to run a Western blot for your protein of interest to
determine its exact position on the membrane (see Supplemen-
tary Figure 1A in [8] as an example). This can be used to guide
the later cutting process.
At the optimal RNase concentration (1:250), the recovered
RNAs are in the range between 50 and 300 nucleotides (Fig. 3B).
Higher RNase concentration (1:50) leads to a sharp band of pro-
tein–RNA complexes (Fig. 3A), which corresponds to RNA mole-
cules smaller than 60 nt (Fig. 3B). RNase concentration of 1:500
or lower resulted mainly in RNA molecules longer than 200 nt,
and reduced the overall signal (Fig. 3B), indicating that the large
size of protein–RNA complexes obstructed gel migration and/or
transfer to the nitrocellulose membrane. These results demon-
strate the importance of optimizing the RNase concentration. In
agreement with a previous study [24], the distinct size ranges ac-
quired from different regions of the nitrocellulose membrane show
that 70 nt of attached RNA shift the migration of protein–RNA
complexes by approximately 20 kDa (compare size fragment C in
Fig. 3A and B). In order to collect a broad spectrum of RNAs, we rec-8 If monitoring depletion efﬁciency, save 15 ll supernatant for Western blot
analysis (see Footnote 6).ommend cutting a wide region corresponding to fragments B–D in
Fig. 3A for the iCLIP cDNA library preparation.9
For RBPs that bind relatively low amounts of RNA, autoradio-
graphs usually result in faint bands or smear (depending on the ex-
tent of partial digestion), due to the small amount of crosslinked
RNA. The protocol can be used for the library preparation with
small amounts of input RNA. However, it is important to compare
the PCR gel and sequencing results of a weak RBP with results from
a no-antibody control, in order to conﬁrm that the cDNAs do not
originate from non-speciﬁcally bound or contaminating RNAs.
Beside RNase I, we have tried other nucleases such as micrococ-
cal nuclease, RNase T2 Benzonase and Cyanase (data not shown).
Most of these had limited RNase digestion activity compared to
RNase I, probably due to buffer incompatibility. RNase T2 showed
good RNase activity in the iCLIP lysis buffer, but was not used fur-
ther because of a preference for cleaving after adenosines.
3.3. RNA 30 end dephosphorylation10
 Discard the supernatant and resuspend the beads in 20 ll of the
following mixture:
4 ll 5  PNK pH 6.5 bufferdoes not use A
RNA, thereby p
yield of iCLIP
circularization0.5 ll PNK
0.5 ll RNasin
15 ll H2O Incubate for 20 min at 37 C in a thermomixer at 1100 rpm.
 Wash with PNK buffer.
 Wash with high-salt wash (rotate wash in the cold room for at
least 1 min).
 Wash twice with PNK buffer.
Test: dephosphorylation. The dephosphorylation step is critical to
remove the cyclic phosphate that remains at the RNA 3’ end after par-
tial RNase I digestion since it prevents adapter ligation (see below).
Current CLIP protocols use either Polynucleotide Kinase (PNK; later
also used in the 50 end labeling reaction) or Shrimp Alkaline Phospha-
tase (SAP) for this purpose. We compared the efﬁciency of both en-
zymes in the iCLIP protocol by measuring the amount of ampliﬁed
cDNA after library preparation (Fig. 3C). PTB–RNA complexes treated
with PNK for 20 min showed the highest library concentration, indi-
cating efﬁcient removal of the inhibitory cyclic phosphate from 30
ends. Prolonged treatment with PNK up to 2 h decreased rather than
improved the cDNA yield, probably due to loss of immunopuriﬁed
protein–RNA complexes (not shown). In contrast to PNK, the SAP
treatment showed almost no effect when compared to no treatment
(Fig. 3C). Consistently, enzymatic activity to remove cyclic phosphate
has been described for PNK but not SAP [25]. We therefore recom-
mend using PNK for 30 end dephosphorylation.
3.4. L3 adapter ligation
 Carefully remove the supernatant and resuspend the beads in
20 ll of the following mix11:TP and can only ligate a 50 pre-adenylated linker to the 30-OH of the
recluding RNA self-circularization. In our hands, it did not improve the
libraries, presumably because loss of RNA molecules due to self-
is minor.
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5 ll 4X ligation buffer m
1 ll RNA ligase11  A
0.5 ll RNasin p
1.5 ll pre-adenylated adapter L3-App (20 lM) a
4 ll PEG400  A Incubate overnight at 16 C in a thermomixer at 1100 rpm.
 Add 500 ll PNK buffer.
 Wash twice with high-salt buffer, rotating each wash in the cold
room for 5 min, and twice with PNK buffer.
3.5. 50 end labeling
 Collect 200 ll (20%) of beads from step 3.5 and remove the
supernatant.
 Add 4 ll of hot PNK mix:0.2 ll PNK  Centrifuge at 15,000 rpm at 4 
0.4 ll c-32P-ATP natant and wash the pellet w15
0.4 ll 10x PNK buffer again for 5 min. Resuspend th3 ll H2O to a PCR tube. Incubate 5 min at 37 C in a thermomixer at 1100 rpm.14 In order to determine the speciﬁcity of the protein–RNA complex, it is necessary to
check the high RNase condition. The radioactive band of the high RNase experiment
should be 5 kDa above the molecular weight, there should be no band appearing in
any of the controls and the band should shift up and become more diffuse in the low-
RNase condition. On this basis, proceed to RNA isolation using the following guidelines: Discard the supernatant as radioactive waste and add 20 ll 1x
NuPAGE loading buffer.
 Remove the supernatant from the remaining cold beads. Then
add the radioactively labeled beads to the cold beads.
 Incubate 5 min at 70 C.
 Place on the magnet, collect the supernatant and load it on the
gel.
3.6. SDS–PAGE and nitrocellulose transfer
 Load the samples on a 4–12% NuPAGE Bis-Tris gel12. Also load
5 ll of a pre-stained protein size marker. Use 0.5 l 1x MOPS
running buffer.
 Run the gel at 180 V for 50 min.
 Cut off the dye front and discard it as solid radioactive waste (it
contains the unincorporated radioactive ATP).
 Transfer the protein–RNA complexes from the gel to a Protran
Nitrocellulose Membrane using the Novex wet transfer appara-
tus according to the manufacturer’s instructions.
 Transfer at 30 V for 1 h.
 After the transfer, rinse the membrane in PBS buffer, then wrap
it in saran wrap and expose it to a Fuji ﬁlm at 80 C. Perform
exposures for 30 min, 1 h and overnight.13
3.7. Library preparation
3.7.1. RNA isolation
 Isolate the protein–RNA complexes from the low RNase condi-
tion using the autoradiograph as a mask for cutting the respec-uPAGE gels are critical. A pour-your-own SDS-PAGE gel (Laemmli)
ring the run which can get to pH 9.5 leading to alkaline hydrolysis
ead, the Novex NuPAGE buffer system keeps the pH around 7
hole run. We use MOPS NuPAGE running buffer.
RNases, RNase I has no base preference, and therefore cleaves after
s. Under high-RNase conditions, the size of the radioactive band has
mparison to low RNase conditions, conﬁrming that the band
protein–RNA complex. Furthermore, the high-RNase condition helps
size of the immunoprecipated RBP, as the RBP will be bound to short
will migrate as a less diffuse band 5 kDa above the expected
of the protein.ive region out of the nitrocellulose membrane. Place the
embrane fragments into 1.5 ml tubes.14
dd 10 ll proteinase K in 200 ll PK buffer to the nitrocellulose
ieces (all should be submerged). Incubate for 20 min shaking
t 1100 rpm at 37 C.
dd 200 ll PK buffer + 7 M urea and incubate for further 20 min
at 37 C and 1100 rpm.
 Collect the solution and add it together with 400 ll phenol/
chloroform to a 2 ml Phase Lock Gel Heavy tube.
 Incubate for 5 min at 30 C shaking at 1100 rpm. Separate the
phases by spinning for 5 min at full speed and room temperature.
 Transfer the aqueous layer into a new tube (be careful not to
touch the gel matrix with the pipette). Optional: spin again
for 1 min and transfer into a new tube.
 Precipitate by adding 0.75 ll glycoblue and 40 ll 3 M sodium
acetate pH 5.5. Then mix and add 1 ml 100% ethanol, mix again
and place at 20 C overnight.
C for 20 min. Remove the super-
ith 0.9 ml 80% ethanol and spin
e pellet in 5 ll H2O and transfer
3.7.2. Reverse transcription
 Add the following reagents to the resuspended pellet16:
1 ll primer Rt#clip (0.5 pmol/ll)
1 ll dNTP mix (10 mM)
 RT thermal program:
 70 C 5 min
 25 C hold until the RT mix is added, mix by pipetting
 RT mixth
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4 ll 5  First Strand Buffer
1 ll 0.1 M DTT
0.5 ll RNasin
0.5 ll Superscript III 25 C 5 min, 42 C 20 min, 50 C 40 min, 80 C 5 min, 4 C hold Add 1.65 ll 1 M NaOH and incubate at 98 C for 20 min. Then
add 20 ll 1 M Hepes–NaOH pH 7.3 to eliminate radioactivity
from strongly labeled samples and to prevent RNA from inter-
fering with subsequent reactions.17
 Add 350 ll TE buffer, 0.75 ll glycoblue and 40 ll 3 M sodium
acetate, pH 5.5, mix, then add 1 ml 100% ethanol. Mix again
and precipitate at 20 C overnight.cular weight of 70 nt RNA is20 kDa. To isolate a broad range of RNAs
00 nt in size (including the adapter), we recommend cutting a wide
Da above the expected molecular weight of the protein.
ash ﬁrst with a p1000 and then with a p20 or p10. Try not to disturb
ou do, spin it down again. Leave on the bench for exactly 3 min with
ry. When resuspending, make sure to pipette along the back area of
primers (Rt1clip–Rt16clip) for the control and the different exper-
s. The different primers contain individual 4-nt barcode sequences
lexing of samples and control for cross-contamination between the
to mix up to three samples that shall be multiplexed at this point.
NA libraries of each sample can be ampliﬁed separately and mixed
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Fig. 4. Quality improvements of library preparation and urea treatment. (A) Reverse transcription (RT) primers can differ in their efﬁciency. Different reverse transcription
primers were tested by analyzing hnRNP C iCLIP libraries using gel electrophoresis. RT primers Rt#clip 1, 2, 6, 9, 10 and 13–16 were identiﬁed as the most useful for library
preparation. Note that in this experiment also the control omitting the antibody shows product on the PCR gel, indicating some impurities in the puriﬁcation. For the
evaluation of the primer quality this does not have an impact. Furthermore, the signal of the product is much weaker when compared to the sample that was reverse
transcribed with the same RT primer (Rt9clip). (B) Alkaline hydrolysis efﬁciently removes radioactively labeled RNA and does not impair library preparation. Gel image of
ampliﬁed cDNA libraries using RT primers Rt1clip and Rt2clip and extraction of low and medium size ranges (L, 70–80 nt; M, 80–100 nt). Samples were treated with or
without alkaline hydrolysis. Radioactive counts per second before RT and after gel extraction are given above. (C) Increased numbers of PCR ampliﬁcation cycles lead to the
formation of secondary products. hnRNP C iCLIP libraries were ampliﬁed using between 21 and 39 cycles. The appearance of secondary products beyond 31 cycles indicates
overampliﬁcation. 1/10 and 1/100 dilutions of cycle number 35 and 39 are shown for comparison.
I. Huppertz et al. /Methods 65 (2014) 274–287 283Test: RT primers. All reverse transcription primers are equipped
with 5-nt random barcodes to enable removal of PCR artifacts, plus
a 4-nt barcode sequences that allow multiplexing. The 4-nt bar-
codes differ by at least two nucleotides, insuring that a single point
mutation is not sufﬁcient to convert one barcode into another.Since the quality of the library depends on the efﬁciency of the
individual primer, it is necessary to test each new primer
(Fig. 4A). In order to do so, a full library preparation is needed (a
well-established antibody can be used for immunoprecipitation
of protein–RNA complexes, which are then used for reverse
284 I. Huppertz et al. /Methods 65 (2014) 274–287transcription with different RT primers). It is advisable to include
an already optimized primer as a reference for the newly ordered
primers. The intensity of the PCR-ampliﬁed library on a TBE gel ac-
quired from the preparative PCR can be used to estimate the qual-
ity of a speciﬁc RT primer. From Fig. 4A it can be concluded that the
Rt#clip primers 1, 2, 6, 9, 10 and 13–16 were the most reliable in
our hands. However, this depends on the individual batch and
can vary between different orders. We advice to keep negative con-
trols separate to estimate the unspeciﬁc background signal before
the sequencing reaction.
Test: alkaline hydrolysis. After the RNA is released with proteinase
K, the samples can still be radioactive. Alkaline hydrolysis can be
used to remove the carry-over of radioactively labeled RNA after
reverse transcription. In this test, the counts/s of each sample were
measured before and after the alkaline treatment. This conﬁrmed
that alkaline hydrolysis degrades the RNA and removes all remain-
ing radioactive signal (Fig. 4B). Use of two different RT primers
conﬁrmed that the same amount of PCR product is recovered inde-
pendent of the alkaline hydrolysis, indicating that this treatment
did not inﬂuence the quality of the library preparation.
3.7.3. Gel puriﬁcation
 Centrifuge for 15 min at 15,000 rpm at 4 C. Remove the super-
natant and wash the pellet with 0.5 ml 80% ethanol. Centrifuge
again, remove supernatant and resuspend the pellet in 6 ll H2O.
 Add 6 ll 2  TBE-urea loading buffer to the cDNA. It is recom-
mended, at least in initial experiments, to add the loading buffer
also to 6 ll DNA size marker. Heat samples to 80 C for 5 min
immediately before loading. Leave one lane free between each
sample to avoid cross-contamination between samples.
 Prepare 0.8 l 1x TBE running buffer and ﬁll the upper chamber
with 0.2 l and the lower chamber with 0.6 l. Use a p1000 pipette
to ﬂush remaining urea out of the wells before loading 12 ll of
each sample. Load the marker into the last lane.
 Run 6% TBE-urea gel for 40 min at 180 V until the lower (dark
blue) dye is close to the bottom.
 Cut off the last lane containing the size marker and incubate it
gently shaking for 10 min in 20 ml TBE buffer with 2 ll SYBR
green II. Wash once with TBE and visualize by UV transillumina-
tion. Print the result with 100% scale, and use it as a mask to
guide the excision of cDNA bands from the rest of the gel.
 Together with the full L3-App sequence, the primer sequence
accounts for 52 nt of the cDNA. Cut three bands, at 70–80 nt,
80–100 nt and 100–150 nt.18
 Add 400 ll TE to each gel piece and crush the gel piece into
small pieces with a 1 ml syringe plunger.
OR
 Prepare 0.5 ml tubes by piercing a hole in the bottom using a
19G needle. Place a gel fragment inside and then place the tubes
into a 2 ml collection tube. Centrifuge 2 min at full speed.
Remove 0.5 ml tube and add 400 ll TE.
 Incubate shaking for 1 h at 1100 rpm at 37 C for, then place on
dry ice for 2 min, and place back for 1 h at 1100 rpm at 37 C.
Transfer the liquid portion of the supernatant into a Costar
SpinX column, into which you placed two 1 cm glass pre-ﬁlters.
 Centrifuge at full speed for 1 min. Collect the solution and add it
together with 400 ll RNA phenol/chloroform to a 2 ml Phase
Lock Gel Heavy tube.18 The 70–80 nt band is prone to producing primer artifacts in the PCR, and even if
containing speciﬁc cDNAs, sequences are often too short to map to the genome.
Therefore, if binding to miRNAs or other short RNAs is not of interest, it is not
necessary to isolate this band. Incubate for 5 min shaking at 1100 rpm at 30 C. Separate the
phases by spinning 5 min at full speed at room temperature.
 Transfer the aqueous layer into a new tube. Centrifuge again for
1 min and transfer into a new tube.
 Add 1 ll glycoblue and 40 ll 3 M sodium acetate, pH 5.5. Mix,
then add 1 ml 100% ethanol. Mix again and precipitate at
20 C overnight.
3.7.4. Ligation of the primer to the 50 end of the cDNA (circularization)
 Pellet the precipitated cDNA by centrifugation, wash as
described above and resuspend in 8 ll ligation mix:6.5 ll H2O
0.8 ll 10x CircLigase buffer II
0.4 ll 50 mM MnCl2
0.3 ll CircLigase II Transfer to PCR tubes and incubate at 60 C for 1 h.
 Add 30 ll oligo annealing mix:26 ll19 All work d
cDNA must nH2O
3 ll Fast digest buffer
1 ll 10 lM Cut_oligo Anneal the oligonucleotide with the following program:
95 C 2 min.
Successive cycles of 20 s, starting from 95 C and decreasing
the temperature by 1 C each cycle down to 25 C.
25 C hold. Add 2 ll BamHI and incubate for 30 min at 37 C, then incubate
for 5 min at 80 C.
 Add 350 ll TE, 0.75 ll glycoblue and 40 ll 3 M sodium acetate,
pH 5.5, and mix. Then add 1 ml 100% ethanol. Mix again and
precipitate at 20 C overnight.
3.8. PCR ampliﬁcation
3.8.1. PCR optimization
 Centrifuge and wash the cDNA, then resuspend it in 21 ll H2O.
 Prepare the following PCR mix:1 ll cDNA
0.25 ll primer mix P5Solexa/P3Solexa, 10 lM each
5 ll Accuprime Supermix 1
3.75 ll H2O Run the following PCR:
94 C 2 min
25–35 cycles of: 94 C 15 s, 65 C 30 s, 68 C 30 s
68 C 3 min
25 C hold Mix 8 ll PCR product with 2 ll 5x TBE loading buffer, load on a
6% TBE gel and stain with SYBR green I.193.8.1.1. Test: PCR ampliﬁcation. The size of the cDNA insert to be
mapped to the genome will be the size of product minus the com-
bined length of the P3/P5Solexa primers and the barcode (128 nt).
Therefore, a band cut at 70–80 nt on the cDNA gel (with 20–30 nt
cDNA + 52 nt primer) is expected to generate 145–155 nt PCR
products. A common problem is overampliﬁcation during the
PCR, which results in secondary products that migrate as a diffuse
band of higher size (Fig. 4C). To avoid overampliﬁcation of yourone post PCR must be carried out on a specially designated bench. This
ever be taken to an area where work with iCLIP RNA is done.
I. Huppertz et al. /Methodlibrary, it is necessary to determine the optimal PCR cycle number
for your cDNA. To demonstrate this, an hnRNP C library was ampli-
ﬁed with cycles ranging from 21 to 39, increasing by two cycles be-
tween the lanes (Fig. 4C). Ampliﬁcation with less than 27 cycles
resulted in a weak signal, indicating that the DNA concentration
is not high enough for high-throughput sequencing. On the other
hand, ampliﬁcation with more than 31 cycles led to the appearance
of the secondary band, and with more than 33 cycles reduced the
intensity of the expected band (80–100 nt).
The secondary band could correspond to PCR artifacts, or it could
be an artifact of gel migration, caused by the high concentration of
DNA. To test this, we loaded the gel with 1/10 or 1/100 diluted PCR
products obtained after 35 and 39 cycles. The dilution of the ampli-
ﬁed cDNA did not remove the secondary products, but just weak-
ened the overall signal (Fig. 4C). Since the secondary products
could not be removed by dilution, we conclude that they are PCR
artifacts, which need to be avoided before submitting the cDNA li-
brary for sequencing. For the cDNA used here, cycle numbers be-
tween 27 and 29 would be appropriate for sequencing, since they
produce the correct PCR product of ±150 nt, while the secondary
products are hardly detectable.
3.8.2. Preparative PCR
Estimate the minimum number of PCR cycles based on the re-
sults in Section 3.8.1, and use it to amplify ½ of the library. Con-
sider that a 2.5-fold more concentrated cDNA is used, therefore
we recommend to use one cycle less than in the test PCR.
 Prepare the following PCR mix:
10 ll cDNA2
th
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e ratio by the
ore of the low
mple contains
clude it. Also
actions was o
pliﬁcation.binding sites [7]. For further details, read
review [6].9 ll H2O
1 ll primer mix P5Solexa/P3Solexa, 10 lM each 3.10. Immunoprecipitation under denaturi
20 ll Accuprime Supermix 1 (alternative procedure to 3.2) Run the same PCR program as in step 3.8.1.
 Mix 8 ll PCR product with 2 ll 5x TBE loading buffer, load on a
6% TBE gel and run at 180 V and 120 mA for 30 min. Stain and
visualize with SYBR green I.
 If under-ampliﬁed (i.e., the band is not clearly visible on the
gel), immediately place back into the PCR machine for two or
more cycles and re-run the gel.
 Now amplify the remaining ½ of the cDNA with the appropriate
number of cycles, and combine it with the other ½ PCR reaction.
 If the resulting product sizes are correct, mix the PCR reactions
from cDNAs that were excised from the different portions of the
gel (3.7.3) in the following ratios: lower:middle:high
= 1:5:5.20
3.9. qPCR quantitation
 Set up serial dilutions of all libraries to be tested in a 96-well
plate. Prepare a 1:10 dilution to start with. Use 1:100, 1:1000,
1:10,000 and 1:10,000, ideally with a multichannel pipette for
maximum consistency. Also set up dilutions of an old iCLIP
library of known concentration at 1000,100, 10, 1 and 0.1 pM.the bands can be adjusted according to the following criteria. Adjust
size of cDNAs of interest; for instance, if miRNAs are important, use
er bands. Take the quality of each PCR sample into account; if a
the primer artifact band at 128 nt, then use less of this sample, or
take the quality of the ampliﬁcation into account; if one of the ½ PCR
verampliﬁed, use more of the reaction that is in the right range of Prepare a master mix with the following reagents (18 ll for
each qPCR reaction):s 65 (2014) 274–287 28510 ll Invitrogen Platinum qPCR Supermix w/ROX
0.5 ll DLP oligo (10 lM)
0.6 ll primer 1 (10 lM)
0.6 ll primer 2 (10 lM)
6.3 ll H2O Add18 ll perwell in aqPCRplate (MicroAmpFastOptical plates).
 Add 2 ll template from the dilution plate using a multichannel
pipette.
 Seal the plate well with the MicroAmp optical adhesive ﬁlm.
 Run the plate with the following program in the qPCR machine
(normal setting, detector = FAM-TAMRA, passive refer-
ence = ROX): 54 C 2 min, 94 C 10 min, 40 cycles of: 94 C
15 s, 62 C 1 min, 72 C 30 s.
 To calculate the concentrations, plot concentration vs. Ct value
for the standard on a log scale and ﬁt a line to the graph (the R2
value of the line should be >0.99). Use this line to obtain con-
centrations of the unknown samples using their Ct values.
 Dilute the iCLIP library to 10 nM, submit 10 ll for sequencing
and store the rest.
iCLIP libraries can be sequenced using standard Illumina proto-
cols. For cost effectiveness, we recommend 50-nucleotide single-
end runs. Bioinformatic analysis requires de-multiplexing if multi-
ple samples were run within one sequencing lane, mapping reads
to the genome, collapsing of random barcodes and deﬁnition of
ers are referred to a recent
ng urea conditions
In the case that standard iCLIP conditions are not stringent en-
ough to speciﬁcally purify the protein of interest, a dual immuno-
precipitation with urea denaturation can be used instead of the
protocol described in 3.2. This urea denaturation protocol is
adapted from Kiel et al. [26] and presented in the following steps
for FLAG-tagged proteins of interest.
3.10.1. Antibody coupling
 Covalently couple 30 lg of M2 FLAG antibody to 1 mg of Dyna-
beads M-270 Epoxy by following manufacturer’s protocol (Dyn-
abeads Antibody Coupling Kit, Life Technologies), and
resuspend the beads in 100 ll SB (contained in Dynabeads Anti-
body Coupling Kit) per 1 mg beads.
3.10.2. Preparation of antibody-coupled beads for
immunoprecipitation
 Wash 40 ll of the antibody-coupled beads prepared in 3.10.1
with high-salt wash.
 Wash the beads with lysis buffer and resuspend in 40 ll of lysis
buffer.
 Use 40 ll of the beads for each immunoprecipitation
experiment.
3.10.3. Partial RNA digestion and centrifugation
 Resuspend the cell pellet (from step 3.1) in 1 ml lysis buffer
with 1 ll ANTI-RNase and 10 ll Protease Inhibitor Cocktail Set
III, EDTA-free.
25
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ig. 5. Alternative IP using urea treatment. Denaturing urea treatment prevents co-
uriﬁcation of a second RBP of about 40 kDa. FLAG-tagged Staufen 1 (STAU1) was
uriﬁed using the standard iCLIP protocol (no urea treatment) and compared to an
munoprecipitation procedure using denaturing urea treatment.
286 I. Huppertz et al. /Methods 65 (2014) 274–287 Sonicate with Bioruptor plus for ﬁve cycles with alternating 30 s
on/30 s off at low intensity.
 Add 2 ll Turbo DNase and 10 ll RNase I (1:50 or 1:250 dilution
for high and low RNase condition) to the cell lysate for immuno-
precipitation of the FLAG-tagged protein.
 Incubate at 37 C shaking at 1100 rpm for 3 min. After incuba-
tion transfer to ice for >3 min.
 Centrifuge at 22,000  g at 4 C for 10 min and transfer the
supernatant to a new 1.5 ml microtube. Repeat this step.
3.10.4. 1st round of immunoprecipitation
 Add the cell extract to the beads prepared in 3.10.2.
 Rotate the beads/lysate mix at 4 C for 2 h.
 Discard the supernatant and wash twice with high-salt wash
(rotate the second wash for at least 1 min in the cold room).
 Wash the beads with PNK buffer, leave the beads in PNK buffer
until antibody-attached beads are prepared.
3.10.5. Preparation of antibody-attached beads
Antibody-attached beads were prepared as described in 3.2.1
with minor modiﬁcations.
 Add 20 ll of protein G Dynabeads per experiment to a fresh
microtube.
 Wash beads twice with lysis buffer (without protease inhibitor).
This and all following washing steps of the beads are performed
with 900 ll of the respective buffer.
 Resuspend the beads in 20 ll lysis buffer with 2 lg M2 FLAG
antibody per experiment.
 Rotate tubes for 1 h at room temperature.
 Wash with lysis buffer, and wash twice with T-20 IP buffer and
resuspend in 20 ll of T-20 IP buffer. Leave in T-20 IP buffer until
ready to proceed to step 3.10.6.
3.10.6. 2nd round of immunoprecipitation
 Add100 ll ureacrackingbuffer to thebeadsobtainedfrom3.10.4.
 Incubate at 65 C, shaking at 1100 rpm for 3 min to elute the
immunoprecipitated protein.
 Transfer the supernatant to a new 1.5 ml microtube using a
magnetic stand, and add 900 ll T-20 IP buffer with 1 ll ANTI-
RNase, 10 ll Protease Inhibitor Cocktail Set III, EDTA-free, and
1 ll SUPERaseIn.
 Place on magnetic stand.
 Transfer the supernatant to new 1.5 ml microtube in order to
remove any residual beads and add 20 ll of freshly prepared
antibody-attached beads (from step 3.10.5).
 Rotate the beads/supernatant mix at 4 C for 2 h.
 Discard the supernatant and wash the beads twice with high-
salt wash (rotate the second wash for at least 1 min in the cold
room).
 Wash the beads twice with PNK buffer.
Test: iCLIP with denaturing conditions. To assess the efﬁciency of
removing co-purifying proteins with denaturing conditions,
FLAG-tagged Staufen 1 (STAU1) was immunoprecipitated with a
M2-FLAG antibody using either the protocol 3.2 or 3.10, followed
by RNA labeling as described in 3.4 and SDS–PAGE analysis. An
RBP of around 40 kDa co-puriﬁes with STAU1 when using the stan-
dard iCLIP protocol (see no urea treatment in Fig. 5). The denatur-
ing protocol as described in 3.3 removes the signal of the 40 kDa
protein without signiﬁcant loss in the signal of STAU1-RNA com-
plexes (Fig. 5). The efﬁciency of the protocol depends on the pro-
tein of interest. In case of additional bands in the high RNaseF
p
p
imcontrol, the urea protocol would be preferred. However, the input,
cost and duration of the protocol are higher than for the standard
protocol.
4. Conclusion
Here, we provide a detailed iCLIP protocol, with explanations
and experiments that demonstrate how to prepare a high-quality
cDNA library. Moreover, the protocol can be used with UV-A cross-
linking or with denaturing urea puriﬁcation, which broaden the
range of RBPs that can be investigated with iCLIP.
Acknowledgments
We would like to thank the large number of iCLIP users for
many valuable comments that helped to improve this protocol.
We thank Dr. Kathi Zarnack for critical reading of the manuscript.
This work was supported by the Marie Curie Initial Training Net-
work RNPnet 289007, the European Research Council Grant
206726-CLIP and the Medical Research Council Grant number
U105185858. Y.S. is supported by the Nakajima Foundation and
J.A. is supported by the Boehringer Ingelheim Fonds.
References
[1] T. Glisovic, J.L. Bachorik, J. Yong, G. Dreyfuss, FEBS Lett. 582 (2008) 1977–1986.
[2] B.M. Lunde, C. Moore, G. Varani, Nat. Rev. Mol. Cell Biol. 8 (2007) 479–490.
[3] S.D. Auweter, F.C. Oberstrass, F.H. Allain, Nucleic Acids Res. 34 (2006) 4943–
4959.
[4] S. Mili, J.A. Steitz, RNA 10 (2004) 1692–1694.
[5] P. Triﬁllis, N. Day, M. Kiledjian, RNA 5 (1999) 1071–1082.
[6] J. König, K. Zarnack, N.M. Luscombe, J. Ule, Nat. Rev. Genet. 13 (2011) 77–83.
[7] Y. Sugimoto, J. Konig, S. Hussain, B. Zupan, T. Curk, M. Frye, J. Ule, Genome Biol.
13 (2012) R67.
[8] J. König, K. Zarnack, G. Rot, T. Curk, M. Kayikci, B. Zupan, D.J. Turner, N.M.
Luscombe, J. Ule, Nat. Struct. Mol. Biol. 17 (2010) 909–915.
[9] M.L. Anko, M. Muller-McNicoll, H. Brandl, T. Curk, C. Gorup, I. Henry, J. Ule,
K.M. Neugebauer, Genome Biol. 13 (2012) R17.
[10] B. Rogelj, L.E. Easton, G.K. Bogu, L.W. Stanton, G. Rot, T. Curk, B. Zupan, Y.
Sugimoto, M. Modic, N. Haberman, J. Tollervey, R. Fujii, T. Takumi, C.E. Shaw, J.
Ule, Sci. Rep. 2 (2012) 603.
[11] I.E. Schor, D. Lleres, G.J. Risso, A. Pawellek, J. Ule, A.I. Lamond, A.R. Kornblihtt,
PLoS One 7 (2012) e48084.
[12] J.R. Tollervey, T. Curk, B. Rogelj, M. Briese, M. Cereda, M. Kayikci, J. Konig, T.
Hortobagyi, A.L. Nishimura, V. Zupunski, R. Patani, S. Chandran, G. Rot, B.
Zupan, C.E. Shaw, J. Ule, Nat. Neurosci. 14 (2011) 452–458.
[13] Z. Wang, M. Kayikci, M. Briese, K. Zarnack, N.M. Luscombe, G. Rot, B. Zupan, T.
Curk, J. Ule, PLoS Biol. 8 (2010) e1000530.
[14] C. Yao, J. Biesinger, J. Wan, L. Weng, Y. Xing, X. Xie, Y. Shi, Proc. Nat. Acad. Sci.
USA 109 (2012) 18773–18778.
[15] S. Hussain, A.A. Sajini, S. Blanco, S. Dietmann, P. Lombard, Y. Sugimoto, M.
Paramor, J.G. Gleeson, D.T. Odom, J. Ule, M. Frye, Cell Rep. 4 (2013) 255–261.
[16] J.L. Wagnon, M. Briese, W. Sun, C.L. Mahaffey, T. Curk, G. Rot, J. Ule, W.N.
Frankel, PLoS Genet. 8 (2012) e1003067.
[17] J.T. Witten, J. Ule, Trends Genet. 27 (2011) 89–97.
[18] K. Zarnack, J. König, M. Tajnik, I. Martincorena, S. Eustermann, I. Stevant, A.
Reyes, S. Anders, N.M. Luscombe, J. Ule, Cell 152 (2013) 453–466.
I. Huppertz et al. /Methods 65 (2014) 274–287 287[19] J. König, K. Zarnack, G. Rot, T. Curk, M. Kayikci, B. Zupan, D.J. Turner, N.M.
Luscombe, J. Ule, J. Vis. Exp. (2011).
[20] M. Hafner, M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A.
Rothballer, M. Ascano Jr., A.C. Jungkamp, M. Munschauer, A. Ulrich, G.S.
Wardle, S. Dewell, M. Zavolan, T. Tuschl, Cell 141 (2010) 129–141.
[21] A. Castello, B. Fischer, K. Eichelbaum, R. Horos, B.M. Beckmann, C. Strein, N.E.
Davey, D.T. Humphreys, T. Preiss, L.M. Steinmetz, J. Krijgsveld, M.W. Hentze,
Cell 149 (2012) 1393–1406.
[22] L. Windhager, T. Bonfert, K. Burger, Z. Ruzsics, S. Krebs, S. Kaufmann, G.
Malterer, A. L’Hernault, M. Schilhabel, S. Schreiber, P. Rosenstiel, R. Zimmer, D.
Eick, C.C. Friedel, L. Dolken, Genome Res. 22 (2012) 2031–2042.[23] M. Hafner, M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A.
Rothballer, M. Ascano, A.C. Jungkamp, M. Munschauer, A. Ulrich, G.S. Wardle, S.
Dewell, M. Zavolan, T. Tuschl, J. Vis. Exp. (2010).
[24] J. Ule, K. Jensen, A. Mele, R.B. Darnell, Methods 37 (2005) 376–386.
[25] E.A. Galburt, J. Pelletier, G. Wilson, B.L. Stoddard, Structure 10 (2002) 1249–
1260.
[26] J.A. Kiel, K. Emmrich, H.E. Meyer, W.H. Kunau, J. Biol. Chem. 280 (2005) 1921–
1930.
